6-[2-[4-(4-Fluorobenzoyl)-1-Piperidinyl]Ethyl]-2,3-Dihydro-7-Methyl-5H-Thiazolo[3,2A]Pyrimidin-5-One

CAS : 86487-64-1

Ref. 3D-FF102433

Informations sur le produit

• Nom: 6-[2-[4-(4-Fluorobenzoyl)-1-Piperidinyl]Ethyl]-2,3-Dihydro-7-Methyl-5H-Thiazolo[3,2A]Pyrimidin-5-One
• Synonymes: 5H-Thiazolo(3,2-a)pyrimidin-5-one, 6-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-2,3-dihydro-7-methyl-, 6-(2-(4-(p-Fluorobenzoyl)piperidino)ethyl)-2,3-dihydro-7-methyl-5H-thiazolo(3,2-a)pyrimidin-5-one, 6-(2-(4-(p-Fluorobenzoyl)piperidino)ethyl)-2,3-dihydro-7-methyl-5H-thiazolo(3,2-alpha)pyrimidin-5-one, 6-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-2,3-dihydro-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one, 6-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-7-methyl-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one, R 52,245, Setoperona, Setoperona [Spanish], Setoperone [USAN:INN], Setoperonum, Setoperonum [Latin], Unii-Bq67Cs3Q3E

Description

Azaperone is a fatty acid that is used as a pharmaceutical preparation. It has been shown to bind to receptors in the brain, which may lead to its use in the treatment of chronic oral administration. Azaperone has been shown to have agonist activity at 5-HT receptors, leading to its classification as a 5-HT2 receptor agonist. Azaperone has also been shown to have a number of side effects including symptoms such as drooling and restlessness. This may be due to its ability to cause stimulation of dopamine release from neurons in the occipital cortex.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 401.5 g/mol
• Formule: C₂₁H₂₄FN₃O₂S
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C21H24FN3O2S/c1-14-18(20(27)25-12-13-28-21(25)23-14)8-11-24-9-6-16(7-10-24)19(26)15-2-4-17(22)5-3-15/h2-5,16H,6-13H2,1H3
• Code InChI: InChIKey=RBGAHDDQSRBDOG-UHFFFAOYSA-N
• SMILES: Cc1nc2n(c(=O)c1CCN1CCC(C(=O)c3ccc(F)cc3)CC1)CCS2